Destiny Pharma PLC making significant strides towards phase III evaluation of potential breakthrough C.diff treatment
CEO Neil Clark claimed: "We have built substantial development since closing the £10.4mln fairness funding in December 2020 that enabled...

Why Bow Tie Funnel Is Crucial To Your Business
Walking the Sophisticated Asset Management Path: Multi-Strategy Investing with Expert Precision for Sustainable Alpha and Capital Resilience in Toronto
How CMS for Media Companies Supports Video-First Content Strategy
5 Ways Smart Dental Fitouts Can Boost Patient Comfort and Your Profits
What Builders Insurance Really Covers on the Job Site